Skip to main content

Table 2 Relationship of NLR, PLR, AndSII/ALB with ORR and DCR of immunotherapy in NSCLC receiving ICIs and opioids

From: Peripheral blood inflammatory biomarkers neutrophil/ lymphocyte ratio, platelet/lymphocyte ratio and systemic immune-inflammation index/albumin ratio predict prognosis and efficacy in non-small cell lung cancer patients receiving immunotherapy and opioids

Group

N

ORR

χ2

P

DCR

χ2

P

SII/ALB

       

<17.79

37

13(35.14)

7.349

0.007

27(72.97)

9.061

0.003

≥ 17.79

41

4(9.76)

16(39.02)

NLR

       

≤ 3.985

47

13(27.66)

2.386

0.122

28(59.57)

0.945

0.331

>3.985

31

4(12.90)

15(48.39)

PLR

       

≤ 195.005

49

14(28.57)

3.551

0.06

32(65.31)

5.519

0.019

>195.005

29

3(10.34)

11(37.93)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us